Report Detail
Global Recombinant Human Coagulation VIIa Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
- RnM4529689 |
- 26 September, 2024 |
- Global |
- 72 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Recombinant activated factor VII (rFVIIa) binds to exposed tissue factor at the place of tissue and vascular injury. Thrombin generated by this process activates platelets and the coagulation cascade.
According to our (Global Info Research) latest study, the global Recombinant Human Coagulation VIIa market size was valued at US$ 1214 million in 2023 and is forecast to a readjusted size of USD 1552 million by 2030 with a CAGR of 3.6% during review period.
The top three manufacturers of recombinant human coagulation VIIa in the world include Novo Nordisk, LFB SA HEMA Biologics, and GENERIUM, with a total market share of more than 99%. The largest manufacturer is Novo Nordisk, with a market share of more than 95%. North America is the global most important consumer market for recombinant human coagulation VIIa, with a market share of about 45%. In terms of type, the market share of prefilled syringe is over 78%. In the field of application, the market share of congenital hemophilia is about 65%.
This report is a detailed and comprehensive analysis for global Recombinant Human Coagulation VIIa market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Recombinant Human Coagulation VIIa market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Recombinant Human Coagulation VIIa market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Recombinant Human Coagulation VIIa market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Recombinant Human Coagulation VIIa market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Recombinant Human Coagulation VIIa
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Recombinant Human Coagulation VIIa market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, LFB SA HEMA Biologics, AryoGen Pharmed, GENERIUM, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Recombinant Human Coagulation VIIa market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Prefilled Syringe
Vial
Market segment by Application
Congenital Hemophilia
Acquired Hemophilia
Others
Major players covered
Novo Nordisk
LFB SA HEMA Biologics
AryoGen Pharmed
GENERIUM
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant Human Coagulation VIIa product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Recombinant Human Coagulation VIIa, with price, sales quantity, revenue, and global market share of Recombinant Human Coagulation VIIa from 2019 to 2024.
Chapter 3, the Recombinant Human Coagulation VIIa competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Human Coagulation VIIa breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Recombinant Human Coagulation VIIa market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant Human Coagulation VIIa.
Chapter 14 and 15, to describe Recombinant Human Coagulation VIIa sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Recombinant Human Coagulation VIIa Consumption Value by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Prefilled Syringe
- 1.3.3 Vial
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Recombinant Human Coagulation VIIa Consumption Value by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Congenital Hemophilia
- 1.4.3 Acquired Hemophilia
- 1.4.4 Others
- 1.5 Global Recombinant Human Coagulation VIIa Market Size & Forecast
- 1.5.1 Global Recombinant Human Coagulation VIIa Consumption Value (2019 & 2023 & 2030)
- 1.5.2 Global Recombinant Human Coagulation VIIa Sales Quantity (2019-2030)
- 1.5.3 Global Recombinant Human Coagulation VIIa Average Price (2019-2030)
2 Manufacturers Profiles
- 2.1 Novo Nordisk
- 2.1.1 Novo Nordisk Details
- 2.1.2 Novo Nordisk Major Business
- 2.1.3 Novo Nordisk Recombinant Human Coagulation VIIa Product and Services
- 2.1.4 Novo Nordisk Recombinant Human Coagulation VIIa Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Novo Nordisk Recent Developments/Updates
- 2.2 LFB SA HEMA Biologics
- 2.2.1 LFB SA HEMA Biologics Details
- 2.2.2 LFB SA HEMA Biologics Major Business
- 2.2.3 LFB SA HEMA Biologics Recombinant Human Coagulation VIIa Product and Services
- 2.2.4 LFB SA HEMA Biologics Recombinant Human Coagulation VIIa Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 LFB SA HEMA Biologics Recent Developments/Updates
- 2.3 AryoGen Pharmed
- 2.3.1 AryoGen Pharmed Details
- 2.3.2 AryoGen Pharmed Major Business
- 2.3.3 AryoGen Pharmed Recombinant Human Coagulation VIIa Product and Services
- 2.3.4 AryoGen Pharmed Recombinant Human Coagulation VIIa Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 AryoGen Pharmed Recent Developments/Updates
- 2.4 GENERIUM
- 2.4.1 GENERIUM Details
- 2.4.2 GENERIUM Major Business
- 2.4.3 GENERIUM Recombinant Human Coagulation VIIa Product and Services
- 2.4.4 GENERIUM Recombinant Human Coagulation VIIa Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 GENERIUM Recent Developments/Updates
3 Competitive Environment: Recombinant Human Coagulation VIIa by Manufacturer
- 3.1 Global Recombinant Human Coagulation VIIa Sales Quantity by Manufacturer (2019-2024)
- 3.2 Global Recombinant Human Coagulation VIIa Revenue by Manufacturer (2019-2024)
- 3.3 Global Recombinant Human Coagulation VIIa Average Price by Manufacturer (2019-2024)
- 3.4 Market Share Analysis (2023)
- 3.4.1 Producer Shipments of Recombinant Human Coagulation VIIa by Manufacturer Revenue ($MM) and Market Share (%): 2023
- 3.4.2 Top 3 Recombinant Human Coagulation VIIa Manufacturer Market Share in 2023
- 3.4.3 Top 6 Recombinant Human Coagulation VIIa Manufacturer Market Share in 2023
- 3.5 Recombinant Human Coagulation VIIa Market: Overall Company Footprint Analysis
- 3.5.1 Recombinant Human Coagulation VIIa Market: Region Footprint
- 3.5.2 Recombinant Human Coagulation VIIa Market: Company Product Type Footprint
- 3.5.3 Recombinant Human Coagulation VIIa Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Recombinant Human Coagulation VIIa Market Size by Region
- 4.1.1 Global Recombinant Human Coagulation VIIa Sales Quantity by Region (2019-2030)
- 4.1.2 Global Recombinant Human Coagulation VIIa Consumption Value by Region (2019-2030)
- 4.1.3 Global Recombinant Human Coagulation VIIa Average Price by Region (2019-2030)
- 4.2 North America Recombinant Human Coagulation VIIa Consumption Value (2019-2030)
- 4.3 Europe Recombinant Human Coagulation VIIa Consumption Value (2019-2030)
- 4.4 Asia-Pacific Recombinant Human Coagulation VIIa Consumption Value (2019-2030)
- 4.5 South America Recombinant Human Coagulation VIIa Consumption Value (2019-2030)
- 4.6 Middle East & Africa Recombinant Human Coagulation VIIa Consumption Value (2019-2030)
5 Market Segment by Type
- 5.1 Global Recombinant Human Coagulation VIIa Sales Quantity by Type (2019-2030)
- 5.2 Global Recombinant Human Coagulation VIIa Consumption Value by Type (2019-2030)
- 5.3 Global Recombinant Human Coagulation VIIa Average Price by Type (2019-2030)
6 Market Segment by Application
- 6.1 Global Recombinant Human Coagulation VIIa Sales Quantity by Application (2019-2030)
- 6.2 Global Recombinant Human Coagulation VIIa Consumption Value by Application (2019-2030)
- 6.3 Global Recombinant Human Coagulation VIIa Average Price by Application (2019-2030)
7 North America
- 7.1 North America Recombinant Human Coagulation VIIa Sales Quantity by Type (2019-2030)
- 7.2 North America Recombinant Human Coagulation VIIa Sales Quantity by Application (2019-2030)
- 7.3 North America Recombinant Human Coagulation VIIa Market Size by Country
- 7.3.1 North America Recombinant Human Coagulation VIIa Sales Quantity by Country (2019-2030)
- 7.3.2 North America Recombinant Human Coagulation VIIa Consumption Value by Country (2019-2030)
- 7.3.3 United States Market Size and Forecast (2019-2030)
- 7.3.4 Canada Market Size and Forecast (2019-2030)
- 7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
- 8.1 Europe Recombinant Human Coagulation VIIa Sales Quantity by Type (2019-2030)
- 8.2 Europe Recombinant Human Coagulation VIIa Sales Quantity by Application (2019-2030)
- 8.3 Europe Recombinant Human Coagulation VIIa Market Size by Country
- 8.3.1 Europe Recombinant Human Coagulation VIIa Sales Quantity by Country (2019-2030)
- 8.3.2 Europe Recombinant Human Coagulation VIIa Consumption Value by Country (2019-2030)
- 8.3.3 Germany Market Size and Forecast (2019-2030)
- 8.3.4 France Market Size and Forecast (2019-2030)
- 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
- 8.3.6 Russia Market Size and Forecast (2019-2030)
- 8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
- 9.1 Asia-Pacific Recombinant Human Coagulation VIIa Sales Quantity by Type (2019-2030)
- 9.2 Asia-Pacific Recombinant Human Coagulation VIIa Sales Quantity by Application (2019-2030)
- 9.3 Asia-Pacific Recombinant Human Coagulation VIIa Market Size by Region
- 9.3.1 Asia-Pacific Recombinant Human Coagulation VIIa Sales Quantity by Region (2019-2030)
- 9.3.2 Asia-Pacific Recombinant Human Coagulation VIIa Consumption Value by Region (2019-2030)
- 9.3.3 China Market Size and Forecast (2019-2030)
- 9.3.4 Japan Market Size and Forecast (2019-2030)
- 9.3.5 South Korea Market Size and Forecast (2019-2030)
- 9.3.6 India Market Size and Forecast (2019-2030)
- 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
- 9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
- 10.1 South America Recombinant Human Coagulation VIIa Sales Quantity by Type (2019-2030)
- 10.2 South America Recombinant Human Coagulation VIIa Sales Quantity by Application (2019-2030)
- 10.3 South America Recombinant Human Coagulation VIIa Market Size by Country
- 10.3.1 South America Recombinant Human Coagulation VIIa Sales Quantity by Country (2019-2030)
- 10.3.2 South America Recombinant Human Coagulation VIIa Consumption Value by Country (2019-2030)
- 10.3.3 Brazil Market Size and Forecast (2019-2030)
- 10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
- 11.1 Middle East & Africa Recombinant Human Coagulation VIIa Sales Quantity by Type (2019-2030)
- 11.2 Middle East & Africa Recombinant Human Coagulation VIIa Sales Quantity by Application (2019-2030)
- 11.3 Middle East & Africa Recombinant Human Coagulation VIIa Market Size by Country
- 11.3.1 Middle East & Africa Recombinant Human Coagulation VIIa Sales Quantity by Country (2019-2030)
- 11.3.2 Middle East & Africa Recombinant Human Coagulation VIIa Consumption Value by Country (2019-2030)
- 11.3.3 Turkey Market Size and Forecast (2019-2030)
- 11.3.4 Egypt Market Size and Forecast (2019-2030)
- 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
- 11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
- 12.1 Recombinant Human Coagulation VIIa Market Drivers
- 12.2 Recombinant Human Coagulation VIIa Market Restraints
- 12.3 Recombinant Human Coagulation VIIa Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Recombinant Human Coagulation VIIa and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Recombinant Human Coagulation VIIa
- 13.3 Recombinant Human Coagulation VIIa Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Recombinant Human Coagulation VIIa Typical Distributors
- 14.3 Recombinant Human Coagulation VIIa Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Recombinant Human Coagulation VIIa. Industry analysis & Market Report on Recombinant Human Coagulation VIIa is a syndicated market report, published as Global Recombinant Human Coagulation VIIa Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Recombinant Human Coagulation VIIa market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
